Glaxo Smith Kline to pay $750 million fee

Here's one case where people should be glad the government intervenes within the economy. Glaxo Smith Kline, a pharmaceutical producer is being fined $750 million for selling "adulterated" and "unhealthy" drugs at a plant in Puerto Rico that were used to treat infections, nausea, and Type II diabetes. These were labeled unsafe due to their content and false claims were made about their usage. All of this happened between 2001 - 2005, and the civil class action suit was just finalized this year. They agreed to pay the fine instead of potential lawsuits or being shut down. It also raises a solid point about unreliable goods being produced overseas. The safety of our medicines should be produced in more secure and reliable locations where it can be managed easier, even if it means increasing costs for companies.